semaglutide ckd approval just got FDA-approved for kidney disease. This changes everything., January 2025. The FDA approved semaglutide (Ozempic/Wegovy) for a new indication: reducing kidney disease progression in The FDA just approved Ozempic

As we grow older, cell renewal and repair slow down, which can be delayed by getting enough vitamins and nutrients, like vitamin B12

Retatrutide's proposed mechanism of action involves GLP-1 receptor activation to slow gastric emptying and promote satiety, GIP receptor activation to support insulin secretion and adipose tissue regulation, and glucagon receptor agonism, which in trial settings has been associated with increased energy expenditure and lipolysis

Youll also learn strategies for coaching beyond the medication and collaborating with healthcare providers while staying within your professional scope

McKeown, B

The Desir et al

[...] Rated 4 out of 5 Leslie My body composition improved significantly